Trial Profile
Better Outcome With Melatonin Compared to Placebo Administered to Normalize Sleep-wake Cycle and Treat Hypoactive ICU Delirium The Basel BOMP-AID Randomized Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2022
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Delirium
- Focus Therapeutic Use
- Acronyms BOMP-AID
- 17 Jan 2022 Planned End Date changed from 1 Oct 2024 to 1 Dec 2025.
- 17 Jan 2022 Planned primary completion date changed from 1 Oct 2023 to 1 Dec 2024.
- 17 Jan 2022 Status changed from not yet recruiting to recruiting.